Nurse Practitioner, Family · San Antonio, TX
NPI
1558765727
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
5414 Fredericksburg Rd Ste 100a
San Antonio, TX, 78229
Phone (210) 468-0800
Groups this clinician bills Medicare through
Medicare paid, 2023
$17K
305 services
Medicare patients, 2023
128
Average age 74
Drug cost, 2024
$1.8M
2,309 prescriptions
Company payments, 2025
$3,863
From 29 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Kindra Clark was code 99349 (home e&m - new and established), 156 times for 102 patients. In total Kindra Clark billed 305 services in 20 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99349 Home E&M - New and Established | Office | 156 | 102 | $65.60 | $10K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 43 | 29 | $24.40 | $1,049 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 37 | 37 | $105.05 | $3,887 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 13 | 11 | $24.66 | $321 |
By year: 2022 $18K for 281 services; 2023 $17K for 305 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kindra Clark prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 260 prescriptions and refills. In total Kindra Clark wrote 2,309 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 260 | 293 | 56 | $297K |
| Ozempic Semaglutide | 260 | 306 | 61 | $278K |
| Levothyroxine Sodium Generic | 176 | 452 | 79 | $2,050 |
| Rosuvastatin Calcium Generic | 97 | 289 | 45 | $977 |
| Jardiance Empagliflozin | 96 | 191 | 31 | $111K |
| Trulicity Dulaglutide | 85 | 101 | 20 | $97K |
| Atorvastatin Calcium Generic | 66 | 189 | 38 | $743 |
| Metformin Hcl Generic | 53 | 159 | 24 | $438 |
| Metformin Hcl Er Metformin Hcl | 50 | 148 | 24 | $354 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 47 | 99 | 24 | $5,025 |
| Afrezza Insulin Regular, Human | 47 | 57 | 16 | $156K |
| Humalog Kwikpen U-100 Insulin Lispro | 42 | 108 | 21 | $13K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 41 | 97 | 18 | $4,888 |
| Losartan Potassium Generic | 39 | 105 | 18 | $489 |
| Synthroid Levothyroxine Sodium | 35 | 85 | 13 | $3,526 |
Brand drugs: 1,343 claims; generic drugs: 788 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kindra Clark $3,863 ($3,863 in general payments such as food, travel and fees) from 29 companies. The largest payer was Dexcom, Inc. with $529.
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. DXCM | 13 | $529 |
| Novo Nordisk Inc NVO | 17 | $320 |
| Ascensia Diabetes Care Us Inc. | 36 | $289 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $277 |
| Corcept Therapeutics CORT | 14 | $271 |
| Amgen Inc. AMGN | 16 | $228 |
| Sequel Med Tech, LLC | 24 | $214 |
| Lilly USA, LLC LLY | 9 | $195 |
| Xeris Pharmaceuticals, Inc. | 13 | $180 |
| Mannkind Corporation MNKD | 14 | $144 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.